USA flag logo/image

An Official Website of the United States Government

Delivery system development for a reservoir targeted Lyme disease vaccine

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
Program Year/Program:
2012 / STTR
Agency Tracking Number:
R42AI078631
Solicitation Year:
2012
Solicitation Topic Code:
NIAID
Solicitation Number:
PA11-097
Small Business Information
FOODSOURCE LURE CORPORATION
3733 4th TER N BIRMINGHAM, AL 35222-
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 2
Fiscal Year: 2012
Title: Delivery system development for a reservoir targeted Lyme disease vaccine
Agency: HHS
Contract: 2R42AI078631-03A1
Award Amount: $3,000,000.00
 

Abstract:

DESCRIPTION (provided by applicant): The incidence and geographic distribution of Lyme disease in the U.S. has increased steadily since its first description in 1977. Efforts to stem the spread of the disease through controlling the population of its tickvector and/or the mouse reservoirs of the disease have met with only limited success. The only approved human vaccine to protect against Lyme disease was recently removed from the market by its manufacturer further highlighting the need for new approachesto controlling the disease. In this project, we propose the development of an orally-available vaccine targeted towards the mouse and tick reservoirs of the disease. This proposal combines the expertise of Foodsource Lure Corp, a manufacturer of animal baits that is currently involved in the development of wildlife-targeted vaccines for rabies and the laboratory of Dr. Linden Hu at Tufts University. Dr. Hu's laboratory has developed an oral vaccine for mice using a vaccinia virus vector expressing the B.burgdorferi protein outer surface protein A (OspA). Vaccination of mice protects them against infection with B. burgdorferi by feeding ticks as well as protects uninfected ticks from acquiring infection from vaccinated but infected mice giving the vaccinetwo potential mechanisms for decreasing environmental persistence of B. burgdorferi. In phase I of this project, we developed a stable, highly palatable system for delivering the vaccine to mice and shown that it is immunogenic and protective. We also developed and field tested a strategy for bait delivery that maximizes penetration of the vaccine into rodent populations. In this phase II STTR proposal, we will focus on translating our phase I research towards the development of a commercial product. The next step towards commercialization is receiving USDA regulatory approval to produce and distribute the vaccine in field trials. To this end, we propose three aims designed to produce the information required for a USDA application for an animal vaccine. Our goal is to: 1) create the master seed virus (MSV) that will be used for all subsequent development; 2. test the MSV for stability and purity in accordance with stringent USDA standards for commercial products; 3. produce safety data for the vaccine in target and non-target animals; 4. perform simulated field trials in containment that will generate data confirming environmental safety and feasibility of the animal vaccine strategy. At the completion of this phase II proposal, we will have completed all requirements to submit our application for regulatory approval to USDA. Development of reservoir targeted vaccine strategies for controlling vector transmitted diseases will be an important addition to the armamentarium for prevention of human Lyme disease.PUBLIC HEALTH RELEVANCE: Lyme disease is a significant public health problem in the U.S. One potential approach to the control of Lyme disease is to reduce carriage of the organisms in their wild-life reservoirs. In this proposal, we outline a strategy to develop a vaccine, targeted at mice and ticks that serve as the reservoir for the bacteria that causes Lyme disease. By decreasing carriage of the organism in the wildlife reservoirs and vectors, we hope to reduce the incidence of human disease.

Principal Investigator:

Linden T. Hu
617-636-8498
lhu@tuftsmedicalcenter.org

Business Contact:

Martin Klinger
205-908-0708
martklin@mindspring.com
Small Business Information at Submission:

FOODSOURCE LURE CORPORATION
3733 4th TER N BIRMINGHAM, AL 35222-

EIN/Tax ID: 102068951
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
Research Institution Information:
TUFTS UNIVERSITY BOSTON
TUFTS UNIVERSITY
Office of the Vice Provost 136 Harrison Avenue
BOSTON, MA 02111-
Contact: